Seres Therapeutics (MCRB) EPS (Basic) (2014 - 2026)
Seres Therapeutics' (MCRB) quarterly EPS (Basic) came in at -$2.17 in Q2 2026, up 21.92% year-over-year from -$1.78 in Q2 2025, and down 1.17% quarter-over-quarter from -$2.15 in Q1 2026.
Powered by 
Analysis
Seres Therapeutics (MCRB) EPS (Basic) (2014 - 2026) Analysis & Trends
Seres Therapeutics has disclosed EPS (Basic) across 13 years of filings, most recently posting -$2.17 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 21.92% year-over-year to -$2.17; the TTM figure through Jun 2026 stood at -$8.5 (down 332.57% YoY), while the FY2025 annual figure was -$10.36, down 1040.14% from the prior year.
- EPS (Basic) came in at -$2.17 for Q2 2026 at Seres Therapeutics, down from -$2.15 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $14.58 in Q3 2024 to a low of -$13.97 in Q2 2022.
- Average EPS (Basic) over 5 years is -$3.8, with a median of -$3.36 recorded in 2024.
- Year-over-year, EPS (Basic) slumped 1498.12% in 2023 and jumped 291.46% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.41 in 2022, then tumbled by 1498.12% to -$6.5 in 2023, then jumped by 43.75% to -$3.65 in 2024, then soared by 41.53% to -$2.14 in 2025, then retreated by 1.68% to -$2.17 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$2.17 in Q2 2026, -$2.15 in Q1 2026, and -$2.14 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn | -0.40 |
| 10 | Seres Therapeutics | 49.36 Mn | 49.36 Mn | - | -2.17 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.17 |
| Mar 31, 2026 | -2.15 |
| Dec 31, 2025 | -2.14 |
| Sep 30, 2025 | -2.50 |
| Jun 30, 2025 | -2.78 |
| Mar 31, 2025 | -3.06 |
| Dec 31, 2024 | -3.65 |
| Sep 30, 2024 | 14.58 |
| Jun 30, 2024 | -4.34 |
| Mar 31, 2024 | -5.56 |
| Dec 31, 2023 | -6.50 |
| Sep 30, 2023 | -7.62 |
| Jun 30, 2023 | 7.29 |
| Mar 31, 2023 | -11.36 |
| Dec 31, 2022 | -0.41 |
| Sep 30, 2022 | -9.79 |
| Jun 30, 2022 | -13.97 |
| Mar 31, 2022 | -12.21 |
| Dec 31, 2021 | -10.84 |
| Sep 30, 2021 | 14.88 |